SAFETY AND EFFECTIVENESS OF OUTPATIENT INTRAVENOUS ANTIFUNGAL THERAPY IN PEDIATRIC PATIENTS: EXPERIENCE FROM A SINGLE- CENTER COHORT (ESPID 2026) - May 28, 2026 - Abstract #EPV-0069; Pres time: Jun 1, 2026; 07:00 AM - 07:00 PM; Location: E-Poster Area; "Antifungals included liposomal-amphotericin B (3), micafungin (3), anidulafungin (3), isavuconazole (1); 3 received combination dual therapy. All achieved complete response. Conclusions/Learning Points OPAT antifungal therapy was safe and effective in pediatric patients, including those immunocompromised and with relatively long therapies, both administered by parents/guardians and by Hospital at Home service."
Clinical • Infectious Disease
|
|
Tena Rami G. 1; Padilla Moure C. 1; Clemente Bautista S. 2; Renedo Miro B. 2; Carsi Durall A. 1; Martínez Mitjana L. 1; Galindo S. 3; Mendoza Palomar N.A. 3
|